Aptargroup, Inc. (New York Stock Exchange:ATR)
| Market Cap | 7.69B-8.5% |
| Revenue (ttm) | 3.93B+8.9% |
| Net Income | 362.52M-7.4% |
| EPS | 5.53-4.8% |
| Shares Out | 63.82M |
| PE Ratio | 21.51 |
| Forward PE | 19.25 |
| Dividend | $1.92(1.59%) |
| Ex-Dividend Date | Jul 30, 2026 |
| Volume | 605,910 |
| Open | 120.91 |
| Previous Close | 120.25 |
| Day's Range | 119.86 - 121.33 |
| 52-Week Range | 103.23 - 146.91 |
| Beta | 0.34 |
| Analysts | Buy |
| Price Target | 155.00(+28.71%) |
| Earnings Date | Oct 29, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About ATR
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ATR stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of ATR by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Michael T. McCaulHouse / R | Sale$1.00K – $15.00K | Jun 18, 2026 |
| Michael T. McCaulHouse / R | Purchase$15.00K – $50.00K | Jun 12, 2026 |
| Michael T. McCaulHouse / R | Purchase$15.00K – $50.00K | Nov 19, 2025 |
| Michael T. McCaulHouse / R | Purchase$15.00K – $50.00K | Sep 22, 2025 |
| Michael T. McCaulHouse / R | Purchase$1.00K – $15.00K | Sep 11, 2025 |
| Michael T. McCaulHouse / R | Sale$1.00K – $15.00K | Aug 26, 2024 |
| Michael T. McCaulHouse / R | Purchase$1.00K – $15.00K | Nov 1, 2023 |
| Michael T. McCaulHouse / R | Purchase$15.00K – $50.00K | Nov 1, 2023 |
Recently reported changes in ATR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ATR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ATR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ATR Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Adjusted EBITDA | $228.50M | 59.03% |
| Selling, Research & Development and Administrative: | $157.74M | 40.75% |
| Net unrealized investment gain (loss) | $849.00K | 0.22% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ATR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ATR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ATR
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $267.20M |
| VBVanguard Morningstar Small-Cap ETF | $193.28M |
| VBRVanguard Morningstar Small-Cap Value ETF | $122.74M |
| VXFVanguard Extended Market ETF | $97.61M |
| DFATDimensional - US Targeted Value ETF | $72.39M |
| SDYState Street SPDR S&P Dividend ETF | $67.49M |
Estimated from each fund’s disclosed top holdings × AUM
ATR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ATR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score